Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Cash: 2013-2025

Historic Change in Cash for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $11.8 million.

  • Fortress Biotech's Change in Cash rose 168.20% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.5 million, marking a year-over-year increase of 291.79%. This contributed to the annual value of -$24.6 million for FY2024, which is 74.84% up from last year.
  • Fortress Biotech's Change in Cash amounted to $11.8 million in Q3 2025, which was up 169.79% from -$17.0 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Change in Cash peaked at $56.5 million during Q1 2021, and registered a low of -$65.7 million during Q2 2023.
  • For the 3-year period, Fortress Biotech's Change in Cash averaged around -$8.5 million, with its median value being -$7.6 million (2024).
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Change in Cash was 6,279.89% (2021), while the steepest drop was 210.35% (2021).
  • Over the past 5 years, Fortress Biotech's Change in Cash (Quarterly) stood at $53.6 million in 2021, then plummeted by 155.26% to -$29.6 million in 2022, then skyrocketed by 129.10% to $8.6 million in 2023, then tumbled by 124.37% to -$2.1 million in 2024, then soared by 168.20% to $11.8 million in 2025.
  • Its Change in Cash was $11.8 million in Q3 2025, compared to -$17.0 million in Q2 2025 and $33.7 million in Q1 2025.